Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Skrit37on Sep 17, 2020 6:45am
252 Views
Post# 31572894

RE:RE:RE:RE:RE:Moves are being made

RE:RE:RE:RE:RE:Moves are being made
Nailbiter1 wrote:
skiboard09 wrote:

Why is Grail worth so much?  Is it because Bezos is involved?  


is there test better than Aristotle?

has anyone reached out to the company to let them know. 


Yup. I sent the link to IR with a CC to Tripp. I'm sure he's aware of the deal.
Valuation???

Grail has a list of high-profile tech and health-care backers, including Bill Gates, Jeff Bezos, Merck & Co. and Johnson & Johnson, according to its website. The company had filed for an initial public offering this month.

It’s possible that Illumina sees the opportunity as too big to pass up, Palmer said.

“I could imagine a scenario where they have the best look under the hood and see this as potentially being a very large market in the future and wanting to own that asset,” he said.




They best keep looking under the hood to find better sensitivity...untill then it garbage... no wonder they wanna sell it....they tried for years dumping money into it...but its possible the way they detect cancer just simply isnt to the standards of widespread acceptance Goodluck folks
Bullboard Posts